News About: Pharm. Industry
Local hair-regrowth market not big enough for pharmaceutical industry
Catching up with the country's ever-growing anti-alopecia market, leading pharmaceutical firms are biting into the market in hopes of acquiring a larger share.
The local hair market size is estimated to be worth ar...
Ildong's Samion likely to get more sales
Ildong Pharm's Samion (nicergolin), cererovascular medine, is expected to increase as leading ginkgo biloba preparations Ginexin and Tanamin will be non-eligible for health insurance from this May.
Ildong garnere...
VGX Pharmaceuticals grants VGX International to exclusive license for VGX-1027
VGX International announced on February 28 it has granted VGX International an exclusive license to its VGX-1027, lead drug candidate for the treatment of rheumatoid arthritis (RA) and type 1 diabetes (T1D).
VGX-1...
Concerns growing over expanded probe on undue business practice
There is mounting concerns that the ongoing police investigation will expand to the whole pharmaceutical industry as police rounded up hundreds of doctors who are suspected of having taken bribes from pharmaceutical f...
Pharmaceutical firms to ban individual support for scientific eventsThe Korea Pharmaceutical Manufacturers Association said on February 26 it signed a memorandum of understanding (MOU) with the Korean Institute of Medicine and the Korean Medical...
|
Amlopidine market steams up
The domestic amlodipine market is set to heat up as Kukje Pharm and Hyundai Pharm is rushing into the game to bite a bigger pie.
Following the country's No. 1 amlodipine forerunner Pfizer Korea, Hanmi Pharm hit its...
Zydena is under phase 2 clinical studies for portal hypertensionDong-A PharmTech Co., affiliate of Dong-A Pharmaceutical. Co., announced on February 25 that it has initiated a 200 patient, phase 2 clinical study in Europe to investigate the ...
|
Novartis Korea names new presidentNovartis Koreas named Dr. Peter Jager as its new president as of March 1.
Jager, who has been the director of Novatis International AG, will replace Dr. Andrin Oswald who was...
|
Ildong cements ties with Japan's Shionoi
Ildong Pharm has forged its stronger alliance with Japan's leading drug maker Shionogi Co.
Under the agreement, Idong plans to distribute Shionogi's Finibax injection (doripenem hydrate) in 2010 on an exclusive bas...
SK, LG to get Korea's new drug development and technology awards
SK Chemicals, which developed an anti-impotence medicine M-vix will receive the Grand Prize in Korea New Drug Development Awards to be hosted by the Korean Drug Research Association (KDRA) and technology prize at the ...
